糞便管理系統市場機會、成長要素、產業趨勢分析及2026-2035年預測

全球糞便管理系統市場預計到 2025 年將價值 25 億美元，並將以 2.9% 的複合年成長率成長，到 2035 年將達到 34 億美元。

市場擴張主要受全球胃腸道疾病、發炎性腸道疾病和大腸癌發生率上升以及糞便失禁病例增加的推動。老化、慢性疾病、骨盆底併發症和長期用藥導致腸道控制能力下降，使得這些疾病日益普遍。不斷成長的患者群體推動了所有醫療機構對有效且衛生的腸道管理解決方案的持續需求。醫療設備技術的進步也對市場成長起到了重要作用，新型系統提高了廢棄物收集效率，操作簡便，並增強了病患的舒適度。採用親水膠體黏合劑和醫用級矽膠等先進材料可改善皮膚保護，降低滲漏風險，進而改善臨床療效。醫護人員對病人尊嚴和感染控制意識的提高進一步促進了產品的普及。設計和功能的持續創新預計將推動全球醫院、長期照護機構和居家照護機構的長期市場擴張。

預計到2025年，該產品細分市場將佔據80.5%的市場。這一細分市場的成長主要得益於先進的失禁護理解決方案的日益普及，這些方案旨在提高患者舒適度和臨床效率。此類別涵蓋了多種醫療設備專為有效管理糞便失禁而開發，確保安全的廢物處理並提高患者的生活品質。持續的產品創新推動了功能擴展、易用性提升和安全標準的加強，使醫療專業人員能夠提供更可靠、以患者為中心的護理解決方案。預計未來的技術進步將進一步豐富該細分市場的產品種類。

預計到2025年，成人市場規模將達到19億美元。該市場成長的主要驅動力是人口老化。老年人由於生理變化、慢性疾病和長期用藥等原因，更容易出現大便失禁。患有慢性疾病且行動不便的成年人越來越需要非侵入性、便捷的管理方案，以確保衛生、舒適和尊嚴。這種需求持續強勁地推動腸道管理系統在各種醫療機構中的應用，顯著促進了該市場的成長。

到2025年，北美腸道管理系統市佔率將達到40.3%。該地區市場的擴張主要受人口結構顯著變化的驅動，尤其是65歲及以上人口比例的不斷成長。老齡化與胃腸道疾病、神經系統疾病和骨盆底功能障礙的發生率增加密切相關，而這些疾病都會增加大便失禁的風險。因此，醫院、長期照護機構和居家照護機構對先進腸道管理解決方案的需求持續成長，推動了全部區域的市場發展。

貝克頓‧迪金森公司 (Becton Dickinson & Company)、美敦力公司(Medtronic)、科樂普公司 (Coloplast)、貝朗公司 (B. Braun)、康維特公司 (ConvaTec)、霍利斯特公司 (Hollister Incorporated)、丹薩克公司 (Dansac)、HR Healthcare 美國金融業的商業市場的主要企業。這些企業致力於產品創新、提升病患舒適度和增強臨床療效，以增強自身競爭力。他們投資先進的生物材料和防漏技術，以提高安全性和皮膚保護。與醫療機構和醫院建立策略合作夥伴關係，有助於提高產品的普及率和可近性。製造商也優先考慮研發，以設計更人性化、創傷更小的解決方案。隨著長期照護解決方案需求的不斷成長，拓展居家照護領域也成為重點關注方向。此外，每家公司都致力於加強其全球分銷網路，確保嚴格遵守監管規定，並擴展產品系列，從而滿足患者的多樣化需求，並在發達和新興的醫療保健系統中保持長期的市場地位。

目錄

第1章：調查方法

• 研究途徑
• 品質改進計劃
  • GMI人工智慧政策及對資料完整性的承諾
    • 資訊來源一致性協議
• 調查過程和可靠性評分
  • 研究路徑的組成部分
  • 評分組成部分
• 數據收集
  • 主要來源部分列表
• 資料探勘資訊來源
  • 付費資訊來源
    • 區域資訊來源
• 基本估算和計算方法
  • 基準年的計算
• 預測模型
  • 量化市場影響分析
    • 生長參數對預測的數學影響
• 關於調查透明度的補充信息
  • 資訊來源歸屬框架
  • 品質保證指標
  • 對信任的承諾

第2章執行摘要

第3章業界考察

• 生態系分析
• 影響產業的因素
  • 促進因素
    • 糞便失禁和胃腸道疾病的盛行率增加
    • 大腸直腸癌和發炎性腸道疾病（IBD）發生率增加
    • 糞便管理裝置的技術進步
  • 產業潛在風險與挑戰
    • 先進的糞便管理系統高成本
    • 在某些國家，還款額度有限。
  • 機會
    • 開發一種經濟高效的糞便管理解決方案
    • 居家醫療和長期照護領域的成長
• 成長潛力分析
• 監理情勢（基於初步調查）
  • 北美洲
  • 歐洲
  • 亞太地區
• 科技與創新趨勢
  • 當前技術趨勢
  • 新興技術
• 未來市場趨勢（基於初步研究）
• 2025年價格分析（基於初步調查）
• 人工智慧和生成式人工智慧對市場的影響（基於初步研究）
  • 利用人工智慧改造現有經營模式
  • 按細分市場分類的生成式人工智慧用例和部署藍圖
• 還款方案（基於初步調查）
• 波特五力分析
• PESTEL 分析

第4章 競爭情勢

• 介紹
• 企業矩陣分析
• 企業市佔率分析（基於初步研究）
  • 世界
  • 北美洲
  • 歐洲
  • 亞太地區
• 主要市場公司的競爭分析
• 競爭定位矩陣
• 主要進展
  • 併購
  • 夥伴關係與合作
  • 新產品發布
  • 業務拓展計劃

第5章 市場估計與預測：依類型分類，2022-2035年

• 產品
  • 人工肛門袋
  • 清潔系統
  • 神經控制裝置
  • 其他產品
• 配件

第6章 市場估計與預測：依病患類型分類，2022-2035年

• 成人版
• 兒童

第7章 市場估計與預測：依最終用途分類，2022-2035年

• 居家醫療設施
• 醫院
• 門診手術中心

第8章 市場估計與預測：依地區分類，2022-2035年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲（MEA）
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• B. Braun
• Becton, Dickinson and Company
• Coloplast A/S
• Convatec
• Dansac
• Hollister Incorporated
• HR HealthCare
• Medtronic plc
• Peak Medical
• Pelican Healthcare Limited
• Salts Healthcare
• Welland Medical Limited

The Global Stool Management System Market was valued at USD 2.5 billion in 2025 and is estimated to grow at a CAGR of 2.9% to reach USD 3.4 billion in 2035.

Market expansion is supported by the rising prevalence of gastrointestinal disorders, inflammatory bowel disease, colorectal cancer, and increasing cases of fecal incontinence worldwide. The condition is becoming more common due to aging populations, chronic illnesses, pelvic floor complications, and long-term medication use, all of which contribute to reduced bowel control. This growing patient pool is driving consistent demand for effective and hygienic stool management solutions across healthcare settings. Technological advancements in medical devices are also playing a key role in market growth, with newer systems offering improved containment efficiency, greater ease of use, and enhanced patient comfort. The integration of advanced materials such as hydrocolloid-based adhesives and medical-grade silicone is improving skin protection and reducing leakage risks, resulting in better clinical outcomes. Increasing awareness among healthcare providers regarding patient dignity and infection prevention is further encouraging adoption. Continuous innovation in design and functionality is expected to support long-term market expansion across hospitals, long-term care facilities, and homecare environments globally.

The products segment accounted for a share of 80.5% in 2025. Growth in this segment is strongly supported by increasing adoption of advanced continence care solutions designed to enhance patient comfort and clinical efficiency. This category includes a wide range of medical devices developed for the effective management of fecal incontinence, ensuring safe containment and improved quality of life for patients. Continuous product innovation is expanding functionality, improving usability, and enhancing safety standards, allowing healthcare providers to deliver more reliable and patient-focused care solutions. Ongoing technological progress is expected to further broaden the scope of available product offerings in this segment.

The adult segment generated USD 1.9 billion in 2025. Growth in this category is largely driven by the rising aging population, which is more vulnerable to fecal incontinence due to physiological changes, chronic health conditions, and long-term medication use. Adults suffering from chronic illnesses or mobility limitations increasingly require non-invasive and convenient management solutions that ensure hygiene, comfort, and dignity. This demand continues to support strong adoption of stool management systems across various healthcare settings, contributing significantly to segment growth.

North America Stool Management System Market accounted for a 40.3% share in 2025. The region's expansion is supported by significant demographic changes, particularly the growing proportion of individuals aged 65 and above. Aging is closely linked with higher rates of gastrointestinal disorders, neurological conditions, and pelvic floor dysfunction, all of which increase the likelihood of fecal incontinence. As a result, demand for advanced stool management solutions continues to rise across hospitals, long-term care facilities, and home care environments, strengthening overall regional market growth.

Becton, Dickinson and Company, Medtronic plc, Coloplast A/S, B. Braun, Convatec, Hollister Incorporated, Dansac, HR HealthCare, Pelican Healthcare Limited, Peak Medical, Salts Healthcare, and Welland Medical Limited are among the key companies operating in the Stool Management System Market. Companies in the Stool Management System Market are focusing on product innovation, improved patient comfort, and enhanced clinical performance to strengthen their competitive position. They are investing in advanced biomaterials and leak-proof technologies to improve safety and skin protection. Strategic collaborations with healthcare providers and hospitals are helping expand product adoption and improve accessibility. Manufacturers are also prioritizing research and development to design more user-friendly and minimally invasive solutions. Expansion into homecare settings is another key focus area as demand for long-term care solutions increases. Additionally, companies are strengthening global distribution networks, improving regulatory compliance, and enhancing product portfolios to address diverse patient needs and maintain long-term market presence across both developed and emerging healthcare systems.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Type trends
  • 2.2.3 Patient type trends
  • 2.2.4 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of fecal incontinence and gastrointestinal disorders
    • 3.2.1.2 Increasing incidence of colorectal cancer and IBD
    • 3.2.1.3 Technological advancements in stool management devices
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced stool management systems
    • 3.2.2.2 Limited reimbursement in several countries
  • 3.2.3 Opportunities
    • 3.2.3.1 Development of cost-effective stool management solutions
    • 3.2.3.2 Growth in home healthcare and long-term care settings
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape (Driven by Primary Research)
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Future market trends (Driven by Primary Research)
• 3.7 Pricing analysis, 2025 (Driven by Primary Research)
• 3.8 Impact of AI & generative AI on the market (Driven by Primary Research)
  • 3.8.1 AI-driven disruption of existing business models
  • 3.8.2 GenAI use cases & adoption roadmap by segment
• 3.9 Reimbursement scenario (Driven by Primary Research)
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis (Driven by Primary Research)
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Products
  • 5.2.1 Colostomy bags
  • 5.2.2 Irrigation systems
  • 5.2.3 Nerve modulation devices
  • 5.2.4 Other products
• 5.3 Accessories

Chapter 6 Market Estimates and Forecast, By Patient Type, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Adult
• 6.3 Pediatric

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Homecare settings
• 7.3 Hospitals
• 7.4 Ambulatory surgical centers

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 B. Braun
• 9.2 Becton, Dickinson and Company
• 9.3 Coloplast A/S
• 9.4 Convatec
• 9.5 Dansac
• 9.6 Hollister Incorporated
• 9.7 HR HealthCare
• 9.8 Medtronic plc
• 9.9 Peak Medical
• 9.10 Pelican Healthcare Limited
• 9.11 Salts Healthcare
• 9.12 Welland Medical Limited